News
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...
A pharmacist holds boxes of Ozempic, a semaglutide injection drug made by Novo Nordisk, in Provo, Utah, on March 29, 2023.
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
Explore the implications of GLP-1 drugs in managing India's obesity crisis as experts warn of potential misuse and health ...
3h
Zacks Investment Research on MSNNovo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...
Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up to 40% of weight loss from semaglutide ...
Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results